{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02630836",
      "OrgStudyIdInfo": {
        "OrgStudyId": "XCEL-MT-10-03"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "2010-024041-78",
            "SecondaryIdType": "EudraCT Number"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "Banc de Sang i Teixits",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Allogeneic Mesenchymal Stromal Cells in Elderly Patients With Hip Fracture",
      "OfficialTitle": "A Pilot Clinical Trial of ex Vivo Expanded Allogenic Adult Stem Cells Combined With Allogenic Human Bone Tissue (XCEL-MT-OSTEO-BETA) in Proximal Femur Fractures in Elderly Patients"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2017",
      "OverallStatus": "Withdrawn",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "December 2015"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 2017",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2018",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "December 10, 2015",
      "StudyFirstSubmitQCDate": "December 14, 2015",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "December 15, 2015",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "March 16, 2017",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 17, 2017",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Banc de Sang i Teixits",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Fundacion Clinic per a la Recerca Biomédica",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "Prospective, unicenter, randomized, open-label, single-dose, two-arms blinded assessor pilot study. Thirty-two (32) elderly patients with hip fracture will be randomized to one of the two treatment-arms (Xcel-MT-osteo-beta or Standard treatment) and be followed for 12 month with the primary objective of safety. Secondary objectives are efficacy through axial tomography and xRay, clinical efficacy and quality of life questionnaire.",
      "DetailedDescription": "Prospective, unicenter, randomized, open-label, single-dose, two-arms blinded assessor phase I-II pilot study.\n\nThirty-two (32) elderly patients (70-85 years of age) with type 31A2 y 31A3 fracture of the femur (AO/ASIF (Association for the Study of Internal Fixation) classification) admitted at the emergency room of the Hospital Clinic of Barcelona will be randomized 1:1 to one of the two treatment-arms (endomedullary nailing + XCEL-MT-OSTEO-BETA or isolated endomedullary nailing as the standard treatment). Once surgically treated, patients will be followed for 12 month with the primary objective of safety. Secondary objectives are efficacy through axial tomography and xRay, clinical efficacy and quality of life questionnaire (EUROQOL-5D)."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Femoral Neck Fracture"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "mesenchymal stromal cells",
          "stem cells",
          "elderly",
          "allogeneic",
          "bone marrow",
          "bone regeneration",
          "fracture"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Single",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Outcomes Assessor"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "0",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "XCEL-MT-OSTEO-BETA",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Adult ex-vivo expanded mesenchymal stromal cells from allogeneic bone marrow, cryopreserved, to combine with fibrin glue and cancellous human bone tissue + endomedullary nailing",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: XCEL-MT-OSTEO-BETA",
                "Procedure: Surgical treatment"
              ]
            }
          },
          {
            "ArmGroupLabel": "Standard treatment",
            "ArmGroupType": "Other",
            "ArmGroupDescription": "Standard surgical treatment with isolated endomedullary nailing",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: Surgical treatment"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "XCEL-MT-OSTEO-BETA",
            "InterventionDescription": "XCEL-MT-OSTEO-BETA followed by endomedullary nailing",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "XCEL-MT-OSTEO-BETA"
              ]
            }
          },
          {
            "InterventionType": "Procedure",
            "InterventionName": "Surgical treatment",
            "InterventionDescription": "Isolated endomedullary nailing",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Standard treatment",
                "XCEL-MT-OSTEO-BETA"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "safety of XCEL-MT-OSTEO-BETA in proximal femur fractures by Adverse events, physical exam, laboratory tests.",
            "PrimaryOutcomeDescription": "Adverse events, physical exam, laboratory tests.",
            "PrimaryOutcomeTimeFrame": "12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "efficacy through CT scan",
            "SecondaryOutcomeDescription": "assessment of consolidation by determination of Hounsfield units in CT scan",
            "SecondaryOutcomeTimeFrame": "3 months"
          },
          {
            "SecondaryOutcomeMeasure": "efficacy through xRay",
            "SecondaryOutcomeDescription": "assessment of bone callus characteristics by standard radiology",
            "SecondaryOutcomeTimeFrame": "1, 3 and 6 months"
          },
          {
            "SecondaryOutcomeMeasure": "efficacy by clinical assessment",
            "SecondaryOutcomeDescription": "Clinical assessment by visual analogue scale for pain",
            "SecondaryOutcomeTimeFrame": "1, 3 and 6 month"
          },
          {
            "SecondaryOutcomeMeasure": "efficacy by quality of life questionnaire",
            "SecondaryOutcomeDescription": "EUROQoL-5D quality of life questionnaire",
            "SecondaryOutcomeTimeFrame": "3, 6 and 12 month"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatient between70 and 85 years old\nProximal femur fracture type 31A3 31a2 classification AO/ASIF.\nDeambulation prior to fracture.\nWritten informed consent of the patient or family members.\n\nExclusion Criteria:\n\nPresence of implants at proximal femur level.\nPresence of local or systemic septic process.\nSeptic arthritis.\nDementia of any type.\nHematological and biochemical analysis with significant alterations that contraindicate surgery.\nPatients with positive serology for HIV 1 and 2, Hepatitis B, Hepatitis C and syphilis.\nNeoplastic disease detected in the last five years or without complete remission.\nImmunosuppressive status.\nPatients who received corticosteroids in the 3 months prior to study initiation.\nSimultaneous participation in another clinical trial or treatment with another investigational product within 3 months prior to inclusion in the study.\nOther conditions or circumstances that may compromise the patient's participation in the study according to medical criteria.\nPatient refusal to be followed by a period that may exceed the clinical trial itself.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "70 Years",
      "MaximumAge": "85 Years",
      "StdAgeList": {
        "StdAge": [
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Josep Maria Segur, MD, PhD",
            "OverallOfficialAffiliation": "Hospital Clinic of Barcelona",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      }
    },
    "ReferencesModule": {
      "SeeAlsoLinkList": {
        "SeeAlsoLink": [
          {
            "SeeAlsoLinkLabel": "Blood and Tissue Banc of Catalonia",
            "SeeAlsoLinkURL": "http://bancsang.net"
          },
          {
            "SeeAlsoLinkLabel": "Hospital Clínic de Barcelona",
            "SeeAlsoLinkURL": "http://hospitalclinic.org"
          },
          {
            "SeeAlsoLinkLabel": "Hospital Clinic Foundation",
            "SeeAlsoLinkURL": "http://fundacioclinic.org"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022",
      "RemovedCountryList": {
        "RemovedCountry": [
          "Spain"
        ]
      }
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000050723",
            "ConditionMeshTerm": "Fractures, Bone"
          },
          {
            "ConditionMeshId": "D000005265",
            "ConditionMeshTerm": "Femoral Neck Fractures"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000014947",
            "ConditionAncestorTerm": "Wounds and Injuries"
          },
          {
            "ConditionAncestorId": "D000006620",
            "ConditionAncestorTerm": "Hip Fractures"
          },
          {
            "ConditionAncestorId": "D000005264",
            "ConditionAncestorTerm": "Femoral Fractures"
          },
          {
            "ConditionAncestorId": "D000025981",
            "ConditionAncestorTerm": "Hip Injuries"
          },
          {
            "ConditionAncestorId": "D000007869",
            "ConditionAncestorTerm": "Leg Injuries"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M8848",
            "ConditionBrowseLeafName": "Hip Fractures",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M25523",
            "ConditionBrowseLeafName": "Fractures, Bone",
            "ConditionBrowseLeafAsFound": "Fracture",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M7554",
            "ConditionBrowseLeafName": "Femoral Fractures",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M7555",
            "ConditionBrowseLeafName": "Femoral Neck Fractures",
            "ConditionBrowseLeafAsFound": "Femoral Neck Fractures",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M16837",
            "ConditionBrowseLeafName": "Wounds and Injuries",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M22258",
            "ConditionBrowseLeafName": "Hip Injuries",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10033",
            "ConditionBrowseLeafName": "Leg Injuries",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC26",
            "ConditionBrowseBranchName": "Wounds and Injuries"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M17443",
            "InterventionBrowseLeafName": "Fibrin Tissue Adhesive",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "Coag",
            "InterventionBrowseBranchName": "Coagulants"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}